Santos Marcelo Protásio Dos, Gonçalves José Eduardo, Takahashi André Akira Ramos, Britto Bruno Barros, Beraldo Fernando Bray, Waisberg Jaques, Tanno Luciana Kase
Department of Surgery, Hospital do Servidor Público Estadual, IAMSPE, Sao Paulo, SP, Brazil.
Department of Surgery, IAMSPE, Sao Paulo, SP, Brazil.
Acta Cir Bras. 2020;35(6):e202000606. doi: 10.1590/s0102-865020200060000006. Epub 2020 Jul 6.
Purpose To analyze, in aged obese patients, the weight loss, comorbidity control, and safety postoperative complications of bariatric surgery by Roux-en-Y gastric bypass technique. Methods Twenty-seven patients who underwent laparoscopic weight-reducing gastroplasty with Roux-en-Y gastric bypass to treat obesity were included. All patients were ≥ 60 years old at the time of surgery. The Wilcoxon test was used for statistical analysis, and a p-value ≤0.05it was considered significant. Results Ten (90.9%) patients with dyslipidemia were cured (p < 0.001). Nine (81.8%) patients with type 2 diabetes mellitus had total improvement and 2 (18.2%) had partial improvement (p = 0.003). In 23 patients with systemic arterial hypertension, 9 (39.1%) achieved total improvement and 14 (60.9%) partial improvement (p = 0.140). Five (71.4%) patients with obstructive sleep apnea syndrome were cured (p = <0.001). For other comorbidities, no partial improvement or cure was shown. Conclusions Roux-en-Y gastric bypass surgery in obese elderly patients can be performed safely and with low morbidity and mortality rates. The benefits of weight loss and reduced comorbidities are promising and like those of the younger population.
目的 分析老年肥胖患者采用Roux-en-Y胃旁路术进行减肥手术后的体重减轻情况、合并症控制情况及术后并发症的安全性。方法 纳入27例行腹腔镜Roux-en-Y胃旁路减肥术治疗肥胖症的患者。所有患者手术时年龄均≥60岁。采用Wilcoxon检验进行统计分析，p值≤0.05被认为具有统计学意义。结果 10例（90.9%）血脂异常患者治愈（p<0.001）。9例（81.8%）2型糖尿病患者完全改善，2例（18.2%）部分改善（p=0.003）。23例系统性动脉高血压患者中，9例（39.1%）完全改善，14例（60.9%）部分改善（p=0.140）。5例（71.4%）阻塞性睡眠呼吸暂停综合征患者治愈（p<0.001）。对于其他合并症，未显示部分改善或治愈情况。结论 老年肥胖患者行Roux-en-Y胃旁路手术可安全进行，发病率和死亡率较低。减肥和减少合并症的益处显著，与年轻人群相似。
